Compare BNTX & CRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNTX | CRS |
|---|---|---|
| Founded | 2008 | 1910 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.8B | 18.9B |
| IPO Year | 2019 | 1994 |
| Metric | BNTX | CRS |
|---|---|---|
| Price | $88.47 | $379.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 6 |
| Target Price | $134.15 | ★ $393.17 |
| AVG Volume (30 Days) | ★ 1.2M | 556.5K |
| Earning Date | 03-10-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 0.21% |
| EPS Growth | N/A | ★ 100.54 |
| EPS | N/A | ★ 4.52 |
| Revenue | N/A | ★ $2,157,700,000.00 |
| Revenue This Year | N/A | $9.28 |
| Revenue Next Year | $2.61 | $10.46 |
| P/E Ratio | ★ N/A | $85.92 |
| Revenue Growth | N/A | ★ 20.03 |
| 52 Week Low | $79.81 | $138.61 |
| 52 Week High | $124.00 | $412.31 |
| Indicator | BNTX | CRS |
|---|---|---|
| Relative Strength Index (RSI) | 35.78 | 50.04 |
| Support Level | $79.81 | $297.11 |
| Resistance Level | $112.30 | $412.31 |
| Average True Range (ATR) | 3.55 | 16.77 |
| MACD | -1.04 | -3.84 |
| Stochastic Oscillator | 28.52 | 46.77 |
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.